Ilsung Is Co., Ltd. (KRX:003120)
South Korea flag South Korea · Delayed Price · Currency is KRW
15,550
+50 (0.32%)
Feb 12, 2025, 9:00 AM KST

Ilsung Is Revenue

Ilsung Is had revenue of 19.02B KRW in the quarter ending September 30, 2024, with 5.23% growth. This brings the company's revenue in the last twelve months to 74.17B, up 1.35% year-over-year. In the year 2023, Ilsung Is had annual revenue of 78.05B with 27.44% growth.

Revenue (ttm)
74.17B
Revenue Growth
+1.35%
P/S Ratio
1.42
Revenue / Employee
n/a
Employees
n/a
Market Cap
108.30B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202378.05B16.81B27.44%
Dec 31, 202261.25B19.16B45.52%
Dec 31, 202142.09B1.49B3.67%
Dec 31, 202040.60B-7.81B-16.13%
Dec 31, 201948.41B-13.24B-21.48%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Samsung Biologics 4,364.39B
Celltrion 2,876.25B
Yuhan 2,008.84B
SK Biopharmaceuticals 511.33B
SK bioscience 201.30B
Hanmi Pharm. 1,495.50B
Peptron 2.41B
Hanall Biopharma 134.24B
Revenue Rankings